L-257-2019
Agreement ID
L-257-2019
Lead IC
NIAAA
Exclusivity
Exclusive
External Party
Inversago Pharma, Inc
Fiscal Year
2020
Territory
Worldwide
Execution Date
Effective Date
Export Date